跳至主要内容
临床试验/CTRI/2026/02/103600
CTRI/2026/02/103600尚未招募2/3 期

Randomized controlled clinical study to evaluate the efficacy of jalaukavacharana (leech therapy) in thrombophlebitis (vranshotha) with thrombophob gel.

Dr NILESH ASHOK NANDALE1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年3月4日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1

研究概览

简要总结

This Study is Randomized Open Labelled Controlled Clinical Trial Comparing The Safety And Efficacy Of Jaluakavcharana For One Time And Controlled Local Application Of Thrombophoeb Gel For 7 Days BD In 60 Patients Divided in Two Groups And Observed The Visual Infusion Phlebitis Score And VAS Scale.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)

入选标准

  • Subjects of age between 18-70 years.
  • Irrespective of Gender
  • Aagantuj Vranashotha with special focus on Acute Superficial thrombophlebitis.
  • Patients have developed thrombophlebitis due to IV Infusion and medication, trauma and infection of veins.
  • Thromboplebitis involving area less than 5 cm.

排除标准

  • 1.Patients receiving cancer chemotherapy drugs, steroid.
  • 2.patients with known case of coagulopathies, polycythemia vera, buergers disease, mondors disease, DVT ,DM and arteriovenous disorders.
  • 3.Patients with known case of HIV, immunosuppressive disorder,haemophilia, hepatitis B and other blood transmitting infection.
  • 4.lactating mother ,pregnant mother.

研究者

发起方
Dr NILESH ASHOK NANDALE
申办方类型
Other [(self)]
责任方
Principal Investigator
主要研究者

Dr NILESH ASHOK NANDALE

Siddhakala Ayurveda Hospital , Sangamner

研究点 (1)

Loading locations...

相似试验